Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOTECHNICS DANMARK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.6% 5.3% 4.5% 8.3% 2.5% 2.3% 15.7% 15.7%   Credit score (0-100)   42 43 46 28 62 63 12 12   Credit rating   BBB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   189 200 136 88.6 1,497 1,783 0.0 0.0   EBITDA   157 165 85.0 -53.1 727 318 0.0 0.0   EBIT   157 165 85.0 -75.5 726 318 0.0 0.0   Pre-tax profit (PTP)   156.6 161.6 80.8 -195.4 629.2 287.3 0.0 0.0   Net earnings   130.0 125.6 64.4 -177.9 462.4 196.7 0.0 0.0   Pre-tax profit without non-rec. items   157 162 80.8 -195 629 287 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   281 406 471 293 755 797 0.0 0.0   Interest-bearing liabilities   0.0 28.9 234 144 53.7 0.0 0.0 0.0   Balance sheet total (assets)   396 841 859 616 1,508 1,444 0.0 0.0   Net Debt   -30.3 15.0 54.9 135 -25.1 -15.6 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   189 200 136 88.6 1,497 1,783 0.0 0.0   Gross profit growth   0.0% 6.0% -32.3% -34.7% 1,589.8% 19.1% -100.0% 0.0%   Employees   1 1 1 1 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   396 841 859 616 1,508 1,444 0 0   Balance sheet change%   -3.5% 112.5% 2.1% -28.3% 145.0% -4.3% -100.0% 0.0%   Added value   156.6 164.7 85.0 -53.1 747.9 318.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 -22 -1 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   82.9% 82.2% 62.7% -85.2% 48.5% 17.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   38.9% 26.6% 10.0% -10.2% 68.8% 22.3% 0.0% 0.0%   ROI %   56.7% 46.0% 14.9% -13.2% 117.2% 41.0% 0.0% 0.0%   ROE %   55.2% 36.5% 14.7% -46.6% 88.2% 25.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   70.9% 48.3% 54.8% 49.3% 50.1% 55.2% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -19.3% 9.1% 64.6% -255.1% -3.4% -4.9% 0.0% 0.0%   Gearing %   0.0% 7.1% 49.6% 49.2% 7.1% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.6% 21.8% 3.2% 63.6% 102.3% 154.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 1.7 5.1 2.3 1.6 1.1 0.0 0.0   Current Ratio   3.4 1.9 5.3 2.2 2.1 2.2 0.0 0.0   Cash and cash equivalent   30.3 13.8 178.6 8.6 78.8 15.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   276.3 401.9 669.5 321.8 787.6 775.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   157 165 85 -53 374 106 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   157 165 85 -53 363 106 0 0   EBIT / employee   157 165 85 -75 363 106 0 0   Net earnings / employee   130 126 64 -178 231 66 0 0